Computational plasticity

Por Oñate, Eugenio., Owen, Roger.
Publicado em 2007

Studies in the theory of imperialism /

Por Owen, Roger, Sutcliffe, Bob
Publicado em 1972

Particle-based methods fundamentals and applications /

Por Oñate, Eugenio, Owen, Roger
Publicado em 2011

Bronchodilator efficacy and safety of indacaterol 150 μg once daily in patients with COPD: an analysis of pooled data

Por Bleecker, Eugene R, Siler, Thomas, Owen, Roger, Kramer, Benjamin
Publicado em 2011

Onset of action of indacaterol in patients with COPD: Comparison with salbutamol and salmeterol-fluticasone

Por Balint, Beatrix, Watz, Henrik, Amos, Carolynn, Owen, Roger, Higgins, Mark, Kramer, Benjamin
Publicado em 2010

Indacaterol provides 24-hour bronchodilation in COPD: a placebo-controlled blinded comparison with tiotropium

Por Vogelmeier, Claus, Ramos-Barbon, David, Jack, Damon, Piggott, Simon, Owen, Roger, Higgins, Mark, Kramer, Benjamin
Publicado em 2010

Efficacy and safety of indacaterol 150 <it>μ</it>g once-daily in COPD: a double-blind, randomised, 12-week study

Por Piggott Simon, Jack Damon, Prasad Niyati, Siler Thomas, Feldman Gregory, Owen Roger, Higgins Mark, Kramer Benjamin
Publicado em 2010-03-01

Efficacy and safety of indacaterol 150 μg once-daily in COPD: a double-blind, randomised, 12-week study

Por Feldman, Gregory, Siler, Thomas, Prasad, Niyati, Jack, Damon, Piggott, Simon, Owen, Roger, Higgins, Mark, Kramer, Benjamin
Publicado em 2010

UK-based real-time lymphoproliferative disorder diagnostic service to improve the management of patients in Ghana

Por Parkins, Elizabeth, Owen, Roger G., Bedu-Addo, George, Sem, Ohene Opare, Ekem, Ivy, Adomakoh, Yvonne, Bates, Imelda
Publicado em 2009

The Detection of t(14;18) in Archival Lymph Nodes : Development of a Fluorescence in Situ Hybridization (FISH)-Based Method and Evaluation by Comparison with Polymerase Chain React...

Por Barrans, Sharon L., Evans, Paul A.S., O’Connor, Sheila J.M., Owen, Roger G., Morgan, Gareth J., Jack, Andrew S.
Publicado em 2003

The MUK five protocol: a phase II randomised, controlled, parallel group, multi-centre trial of carfilzomib, cyclophosphamide and dexamethasone (CCD) vs. cyclophosphamide, bortezom...

Por Brown, Sarah, Hinsley, Samantha, Ballesteros, Mónica, Bourne, Sue, McGarry, Paul, Sherratt, Debbie, Flanagan, Louise, Gregory, Walter, Cavenagh, Jamie, Owen, Roger, Williams, Cathy, Kaiser, Martin, Low, Eric, Yong, Kwee
Publicado no BMC Hematol (2016)

Minimal residual disease in myeloma by flow cytometry: independent prediction of survival benefit per log reduction

Por Rawstron, Andy C., Gregory, Walter M., de Tute, Ruth M., Davies, Faith E., Bell, Sue E., Drayson, Mark T., Cook, Gordon, Jackson, Graham H., Morgan, Gareth J., Child, J. Anthony, Owen, Roger G.
Publicado no Blood (2015)

Minimal residual disease following autologous stem cell transplant in myeloma: impact on outcome is independent of induction regimen

Por de Tute, Ruth M., Rawstron, Andy C., Gregory, Walter M., Child, J. Anthony, Davies, Faith E., Bell, Sue E., Cook, Gordon, Szubert, Alexander J., Drayson, Mark T., Jackson, Graham H., Morgan, Gareth J., Owen, Roger G.
Publicado no Haematologica (2016)

Recommendations for the diagnosis and initial evaluation of patients with Waldenström Macroglobulinemia: A Task Force from the 8(th) International Workshop on Waldenström Macroglob...

Por Castillo, Jorge J., Garcia-Sanz, Ramon, Hatjiharissi, Evdoxia, Kyle, Robert, Leleu, Xavier, McMaster, Mary L., Merlini, Giampaolo, Minnema, Monique C., Morra, Enrica, Owen, Roger, Poulain, Stephanie, Stone, Marvin, Tam, Constantine, Varettoni, Marzia, Dimopoulos, Meletios, Treon, Steven P., Kastritis, Efstathios
Publicado no Br J Haematol (2016)

Cyclophosphamide, thalidomide, and dexamethasone as induction therapy for newly diagnosed multiple myeloma patients destined for autologous stem-cell transplantation: MRC Myeloma I...

Por Morgan, Gareth J., Davies, Faith E., Gregory, Walter M., Bell, Sue E., Szubert, Alexander J., Navarro Coy, Nuria, Cook, Gordon, Feyler, Sylvia, Johnson, Peter R.E., Rudin, Claudius, Drayson, Mark T., Owen, Roger G., Ross, Fiona M., Russell, Nigel H., Jackson, Graham H., Child, J. Anthony
Publicado em 2012

Cyclophosphamide, thalidomide, and dexamethasone (CTD) as initial therapy for patients with multiple myeloma unsuitable for autologous transplantation

Por Morgan, Gareth J., Davies, Faith E., Gregory, Walter M., Russell, Nigel H., Bell, Sue E., Szubert, Alexander J., Coy, Nuria Navarro, Cook, Gordon, Feyler, Sylvia, Byrne, Jenny L., Roddie, Huw, Rudin, Claudius, Drayson, Mark T., Owen, Roger G., Ross, Fiona M., Jackson, Graham H., Child, J. Anthony
Publicado em 2011

First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial

Por Morgan, Gareth J, Davies, Faith E, Gregory, Walter M, Cocks, Kim, Bell, Sue E, Szubert, Alex J, Navarro-Coy, Nuria, Drayson, Mark T, Owen, Roger G, Feyler, Sylvia, Ashcroft, A John, Ross, Fiona, Byrne, Jennifer, Roddie, Huw, Rudin, Claudius, Cook, Gordon, Jackson, Graham H, Child, J Anthony
Publicado em 2010

Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised cont...

Por Morgan, Gareth J, Child, J Anthony, Gregory, Walter M, Szubert, Alex J, Cocks, Kim, Bell, Sue E, Navarro-Coy, Nuria, Drayson, Mark T, Owen, Roger G, Feyler, Sylvia, Ashcroft, A John, Ross, Fiona M, Byrne, Jennifer, Roddie, Huw, Rudin, Claudius, Cook, Gordon, Jackson, Graham H, Wu, Ping, Davies, Faith E
Publicado em 2011

APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma

Por Walker, Brian A, Wardell, Christopher P, Murison, Alex, Boyle, Eileen M, Begum, Dil B, Dahir, Nasrin M, Proszek, Paula Z, Melchor, Lorenzo, Pawlyn, Charlotte, Kaiser, Martin F, Johnson, David C, Qiang, Ya-Wei, Jones, John R, Cairns, David A, Gregory, Walter M, Owen, Roger G, Cook, Gordon, Drayson, Mark T, Jackson, Graham H, Davies, Faith E, Morgan, Gareth J
Publicado no Nat Commun (2015)

The spectrum and clinical impact of epigenetic modifier mutations in myeloma

Por Pawlyn, Charlotte, Kaiser, Martin F, Heuck, Christoph, Melchor, Lorenzo, Wardell, Christopher P, Murison, Alex, Chavan, Shweta, Johnson, David C, Begum, Dil, Dahir, Nasrin, Proszek, Paula, Cairns, David A, Boyle, Eileen M, Jones, John R, Cook, Gordon, Drayson, Mark T, Owen, Roger G, Gregory, Walter M, Jackson, Graham H, Barlogie, Bart, Davies, Faith E, Walker, Brian A, Morgan, Gareth J
Publicado no Clin Cancer Res (2016)